Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.


December 21, 2020

Weekly review: A coronavirus vaccine is here. What happens next?

Daily Briefing

    Leapfrog grades 2,622 hospitals "A" to "F"; when it could be safe to go back to "normal"; and more.

    A coronavirus vaccine is here. What happens next? (Monday, December 14)

    On Monday, Long Island Jewish Medical Center in New York administered the first authorized doses of a coronavirus vaccine in America, after FDA on Friday issued an emergency use authorization for the vaccine developed by Pfizer and BioNTech. Here's what distribution will look like over the next few weeks.

    Leapfrog grades 2,622 hospitals 'A' to 'F.' How did yours fare? (Tuesday, December 15)

    The Leapfrog Group on Monday released its Fall Leapfrog Hospital Safety Grades, giving about one-third of hospitals an "A" grade, but giving more than 40% of hospitals a "C" or lower.

    FDA scientists just finished evaluating Moderna's vaccine. Here's what they found. (Wednesday, December 16)

    FDA on Tuesday released its first scientific evaluation of Moderna's coronavirus vaccine candidate. Here's what the agency's scientists found—and the next steps for getting the experimental vaccine authorized for use in the United States.

    When will it be safe to go back to 'normal'? Here's what top experts say. (Thursday, December 17)

    Americans are eager to get back to their pre-pandemic lives, when it was safe to gather indoors, go out to dinner, and travel—but when will that be safe? The New York Times posed the question to leading experts, including National Institute of Allergy and Infectious Diseases Director Anthony Fauci. Here's what they said.

    Is Moderna's vaccine safe and effective? Our 8 biggest questions, answered. (Friday, December 18)

    FDA on Friday authorized Moderna's coronavirus vaccine for emergency use in the United States, but is the vaccine truly safe and effective? Advisory Board's Brandi Greenberg dives deep into the details—including how Moderna's vaccine stacks up to Pfizer's vaccine authorized last week.

    Radio Advisory

    Listen to our podcast for health care leaders

    Radio Advisory, a podcast for busy health care leaders.

    There is so much information out there – news, opinions, ideas, you name it – but health care leaders just don't have the time to sift through it and figure out what to do. Making sense of it all is how Advisory Board can help.

    Host and seasoned researcher Rachel Woods talks with industry experts to break down the issues on your mind and offer recommendations on what to do next – each week, in 30 minutes or less.

    Listen Now

    Have a Question?


    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.